Ignite Creation Date:
2025-12-25 @ 1:26 AM
Ignite Modification Date:
2026-06-25 @ 1:23 AM
Study NCT ID:
NCT04355793
Status:
NO_LONGER_AVAILABLE
Last Update Posted:
2021-12-15
First Post:
2020-04-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Expanded Access Program of Ruxolitinib for the Emergency Treatment of Cytokine Storm From COVID-19 Infection
Sponsor:
Incyte Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
INCB 18424-MA-COVID-19-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None